
Greg teaches the capstone course Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on non-profit advisory boards. Greg writes about innovation for Forbes.
Education
- MBA, Harvard University, 2000
- MD, Yale University School of Medicine, 1995
Selected Articles
How Is the Pharmaceutical Industry Responding to COVID-19?
Digital Healthcare Growth Drivers In 2020
Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success
Has Employment Become the Goal of the U.S. Healthcare System?
Patients Left Behind: Rare Dermatologic Conditions Miss the Orphan Drug Development Boom
Working Papers
Medical Tourism, Neurosurgery and Singapore’s Largest Health System
Yale SOM Cases
Population Health Management at Atrius, Yale School of Management Case Study, 2016.
Nomad Health and the Disruption of Physician Staffing Services, Yale School of Management Case Study, 2017.
Cobalt and the Rise of Digital Health, Yale School of Management Case Study, in press.
Everlywell and Creating Access to Lab Testing, Yale School of Management Case Study, in press.
Talkspace and digital health market dynamics, Yale School of Management Case Study, in press.
Medical Tourism, Neurosurgery and Singapore’s Largest Health System, Yale School of Management Case Study, in press.
CRISPR Therapeutics and Editing the Human Genome. Yale School of Management Yale School of Management Case Study, in press.
The Health Data Insurgency, Yale School of Management Case Study, in press.